Диссертация (1173229), страница 24
Текст из файла (страница 24)
161 – 167.213. Al-Katma М.К., Bissada N.F., Bordeaux J.M., Sue J., Askari A.D. Controlof periodontal infection reduces the severity of active rheumatoid arthritis // J.Clin. Rheumatol., 2007, Vol. 13, № 3, P.134 – 137.214. Allen M.R., Ruggiero S.L. A review of pharmaceutical agents and oral bonehealth: how osteonecrosis of the jaw has affected the field // Int. J. Oral Maxillofac.Implants., 2014, Vol. 29, № 1, Р. e45 – 57.136215. Alvarez-Nemegyei J., Buenfil-Rello F.A., Pacheco-Pantoja E.L. Associationbetween body composition and disease activity in rheumatoid arthritis. A systematic review // Reumatol.
Clin., 2016, Vol. 12, № 4, Р. 190 – 195.216. Antal M., Battancs E., Bocskai M., Braunitzer G., Kovács L. An observation on the severity of periodontal disease in past cigarette smokers suffering fromrheumatoid arthritis- evidence for a long-term effect of cigarette smoke exposure?// BMC Oral Health., 2018, Vol. 10 № 18(1), p. 82.217.
Arboleya L., Castañeda S. Osteoimmunology: the study of the relationshipbetween the immune system and bone tissue // Reumatol. Clin., 2013, Vol. 9(5), P.303 – 315.218. Badel T., Pavicin I.S., Carek A.J., Rosin-Grget K., Grbesa D. Pathophysiology of osteonecrosis of the jaw in patients treated with bisphosphonate // Coll.Antropol., 2013, Vol. 37, 2, Р. 645 – 651.219.
Bartold P.M., du Bois A.H., Gannon S., Haynes D.R., Hirsch R.S. Antibacterial and immunomodulatory properties of azithromycin treatment implicationsfor periodontitis // Inflammopharmacology, 2013, Vol. 21, № 4, P. 321 – 338.220. Bartold P.M., Marshall R.I., Haynes D.R.
Periodontitis and rheumatoid arthritis: a review // J. Periodontol., 2005, Vol. 76, № 11 Suppl, P. 2066 – 2074.221. Baule J.A., Buchanan W.W. Clinical Rheumatology, Oxford, 1971, 587 p.222. Bautista-Molano W., Fernández-Avila D., Jiménez R. et all. Epidemiological profile of Colombian patients with rheumatoid arthritis in a specialized careclinic // Reumatol. Clin., 2016, Vol. 12. № 6, Р.
313 – 318.223. Behfarnia P. et al. Serum, saliva, and GCF concentration of RANKL andosteoprotegerin in smokers versus nonsmokers with chronic periodontitis // Advanced Biomedical Research, 2016, Vol. 5, P. 159 –175.224. Belibasakis G.N., Bostanci N. The RANKL–OPG system in clinical periodontology // J. Clin. Periodontol., 2012, Vol.
39, № 3, P. 239 – 248.137225. Bensman T.J., Nguyen A.N., Rao A.P., Beringer P.M. Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cells // Pulm. Pharmacol.Ther., 2012, Vol. 25, № 5, Р. 377 – 382.226. Bezerra M.M., de Lima V., Alencar V.B., Vieira I.B., Brito G.A., RibeiroR.A., Rocha F.A. Selective cyclooxygenase-2 inhibition prevents alveolar boneloss in experimental periodontitis in rats // J.
Periodontol., 2000, Vol. 71, P. 1009 –1014.227. Bhatavadekar N.B., Williams R.C. New directions in host modulation for themanagement of periodontal disease // J. Clin. Periodontol., 2009, Vol. 36, № 2, Р.124 – 126.228. Bhatavadekar N.B., Williams R.C. Modulation of the host inflammatory response in periodontal disease management: exciting new directions // Int. Dent.J., 2009, Vol.
59, № 5, Р. 305 – 308.229. Bhatt R., Hibbert S., Munns C. The use of bisphosphonates in children: review of the literature and guidelines for dental management // Aust. Dent. J., 2014,Vol. 59, № 1, Р. 9 – 19.230. Bhuyan R., Bhuyan S., Panigrahi R., Panigrahi A. Bisphosphonate-inducedosteoradionecrosis // J. Oral. Maxillofac. Pathol., 2013, Vol.
17, № 3, Р. 460 – 462.231. Biyiko D.B., Buduneli N., Kardekuler L., Aksu K., Oder G. Evaluation of tPA, PAI-2, IL-lbeta and PGE(2) in gingival crevicular fluid of rheumatoid arthritispatients with periodontal disease // J. Clin. Periodontol., 2006, Vol. 33, № 9, P.605 – 611.232. Biyikoğlu B., Ricker A., Diaz P.I. Strain-specific colonization patterns andserum modulation of multi-species oral biofilm development // Anaerobe, 2012,Vol. 18, № 4, P.
459 – 470.233. Bozkurt F.Y., Yetkin A.Z., Berker E., Tepe E., Akkuku S. Antiinflammatory cytokines in gingival crevicular fluid in patients with periodontitisand rheumatoid arthritis: a preliminary report // Cytokine, 2006, Vol. 35, № 3-4, P.180 – 185.138234. Branco-de-Almeida L.S., Franco G.C., Castro M.L.
et al. Fluoxetine inhibitsinflammatory response and bone loss in a rat model of ligature-induced periodontitis // J. Periodontol., 2012, Vol. 83, № 5, Р. 664 – 671.235. Brozoski M.A., Lemos C.A., Da Graça Naclério-Homem M., Deboni M.C.Adjuvant aqueous ozone in the treatment of bisphosphonate induced necrosis ofthe jaws: report of two cases and long-term follow-up // Minerva Stomatol., 2014,Vol. 63, № 1-2, P. 35 – 41.236. Buchanan B. Rheumatoid arthritis: London, 1971, P. 120 – 121.237. Buczko P., Zalewska A., Szarmach I. Saliva and oxidative stress in oralcavity and in some systemic disorders // J.
Physiol. Pharmacol., 2015, Vol. 66(1),P. 3 – 9.238. Calderaro D.C., Corrêa J.D., Ferreira G.A. et al.Influence of periodontaltreatment of rheumatoid arthritis: a systematic review and meta-analysis // Rev.Bras. Reumatol. Engl. Ed., 2017, Vol. 57, № 3, P. 238 – 244.239. Campisi G., Fedele S., Fusco V., Pizzo G., Di Fede O., Bedogni A. Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents // FutureOncol., 2014, Vol. 10, № 2, Р. 257 – 275.240. Carpenter E.H., Plant M.J., Hassell A.B., Shadforth M.F., Fisher J., ClarkeS., Hothersall Т.Е., Dawes P.T. Management of oral complications of diseasemodifying drugs in rheumatoid arthritis // Brit.
J. Rheum., 1997, № 36, P. 473 –478.241. Caton J.G., Ciancio S.G., Blieden T.M., et al.Treatment withsubantimicrobial dose doxycycline improves the efficacy of scaling and root planning in patients with adult periodontitis // J. Periodontol., 2000, Vol. 71, Р.
521 –532.242. Caton J., Ryan M.E. Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD) // Pharmacol. Res., 2011,Vol. 63, № 2, Р. 114 – 120.139243. Ceccarelli F., Orrù G., Pilloni A. et al. Porphyromonas gingivalis in thetongue biofilm is associated with clinical outcome in rheumatoid arthritis patients// Clin. Exp. Immunol., 2018, Vol.
194(2), P. 244 – 252.244. Celiker R. Temporomandibular joint involvement in rheumatoid arthritis.Re-lationship with disease activity // Scand. J. Rheumatol., 1995, Vol. 24, № 1, P.22 – 25.245. Chadha G.K., Ahmadieh A., Kumar S., Sedghizadeh P.P. Osseointegrationof dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy: a systematic review // J. Oral Implantol., 2013, Vol.
39, № 4, Р.510 – 520.246. ChappleI.L.Potentialmechanismsunderpinningthenutrition-al modulation of periodontal inflammation // J.А.D.A., 2009, Vol. 140, № 2, Р.178 – 184.247. Chaturvedi R., Gill A.S., Sikri P. Evaluation of the regenerative potential of25% doxycycline-loaded biodegradable membrane vs biodegradable membranealone in the treatment of human periodontal infrabony defects: a clinical and radiological study // Indian J.
Dent. Res., 2008, Vol. 19, № 2, P. 116 – 123.248. Choi I.A., Kim J.H., Kim Y.M. et al. Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea //Korean J. Intern. Med., 2016, Vol. 31, № 5, P. 977 – 986.249. Christou J., Johnson A.R., Hodgson T.A. Bisphosphonate-related osteonecrosis of the jaws and its relevance to children-a review // Int. J.
Paediatr.Dent., 2013, Vol. 23, № 5, P. 330 – 337.250. Chukkapalli S., Rivera-Kweh M., Gehlot P. et al. Periodontal bacterial colonization in synovial tissues exacerbates collagen-induced arthritis in B10.RIII mice// Arthritis Res. Ther., 2016, Vol. 12;18(1), p. 161.251. Clarke G. et al. Minireview: Gut microbiota: the neglected endocrine organ /// Molecular endocrinology. – 2014.
– Vol. 28, № 8. – P. 1221–1238.252. CurtisM.A., PercivalR.S., DevineD., etal.Temperature-140dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses // Infect. Immun., 2011, Vol. 79, № 3, P. 1187 –1193.253. Dash P., Kar B., Mishra A., Sahoo P.K. Effect of Dactylogyrus catlaius(Jain 1961) infection in Labeo rohita (Hamilton 1822): innate immune responsesand expression profile of some immune related genes // Indian J.
Exp. Biol., 2014,Vol. 52, № 3, P. 267 – 280.254. Deas D.E., Mealey B.L. Response of chronic and aggressive periodontitis totreatment // Periodontol. 2000, 2010, Vol. 53, P. 154 – 166.255. Deo V., Bhongade M.L. Pathogenesis of periodontitis: role of cytokinesin host response // Dent. Today, 2010, Vol. 29, № 9, P. 60 – 62.256. Domínguez-Pérez R.A., Loyola-Rodriguez J.P., Abud-Mendoza C. et al. Association of cytokines polymorphisms with chronic periodontitis and rheumatoidarthritis in a Mexican population // Acta Odontol. Scand., 2017, Vol. 75, № 4, P.243 – 248.257. Dybicz M., Perkowski K., Sędzikowska A., Baltaza W., Chomicz L.
Studieson prevalence of infection with Trichomonas tenax identified by molecular techniques – in respect to oral health of patients with various systemic disease requiring immunosuppressive therapy // Ann Parasitol., 2018, Vol. 64(3), P. 193 – 197.258. Dumitrescu A.L.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
